Common herpes medication reduces HIV-1 levels, independent of herpes infection
March 16, 2015 in Case Daily, from Clinical Infectious Diseases
Case Western Reserve researchers play a key role in clinical trials’ groundbreaking results. ACTU co-principal investigators Benigno Rodriguez and Michael Lederman are part of an international team that discovered that a common herpes drug reduces HIV-1 levels—even when patients do not have herpes.
